Assessing the Evidence: Patient Selection of New and Emerging Nonstatin Therapies

Access Activity

Overview / Abstract:

Target Audience
This activity has been designed to address the educational needs of cardiologists and primary care physicians, including lipid specialists, internists, family physicians, pharmacists, nurses, nurse practitioners, and PAs.

Type of Activity
Internet Activity (Enduring Material)
Knowledge

Program Overview
This interactive infographic will review the mechanisms of action and clinical trial data for nonstatin therapies for the lowering of low-density lipoprotein cholesterol (LDL-C).

Learning Objectives
Upon completion of this activity, participants should be better able to:

Discuss strategies to improve the knowledge, skills, or performance of the healthcare team
Distinguish among current and emerging nonstatin LDL-C therapies based on unique characteristics and clinical profiles

Expiration

Jul 30, 2022

Discipline(s)

Physician CME

Format

Online

Credits / Hours

0.25

Accreditation

ACCME, ANCC, ACPE

Presenters / Authors / Faculty

Michelle L. O’Donoghue, MD, MPH

Sponsors / Supporters / Grant Providers

Novartis Pharmaceuticals Corporation

Keywords / Search Terms

Relias LLC Relias, Free CME, Nonstatin, LDL-C therapies Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map